BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15542907)

  • 1. Identification of differentially expressed proteins in pancreatic cancer using a global proteomic approach.
    Rosty C; Goggins M
    Methods Mol Med; 2005; 103():189-97. PubMed ID: 15542907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH; Rustgi AK; Blair IA
    J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteome analysis for the identification of tumor-associated biomarkers in gastrointestinal cancer.
    Fels LM; Buschmann T; Meuer J; Reymond MA; Lamer S; Röcken C; Ebert MP
    Dig Dis; 2003; 21(4):292-8. PubMed ID: 14752218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic technologies and their application to pancreatic cancer.
    Vimalachandran D; Costello E
    Expert Rev Proteomics; 2004 Dec; 1(4):493-501. PubMed ID: 15966844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic approaches to the diagnosis, treatment, and monitoring of cancer.
    Wulfkuhle JD; Paweletz CP; Steeg PS; Petricoin EF; Liotta L
    Adv Exp Med Biol; 2003; 532():59-68. PubMed ID: 12908550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen gamma overexpression in pancreatic cancer identified by large-scale proteomic analysis of serum samples.
    Bloomston M; Zhou JX; Rosemurgy AS; Frankel W; Muro-Cacho CA; Yeatman TJ
    Cancer Res; 2006 Mar; 66(5):2592-9. PubMed ID: 16510577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Identification of differentially expressed proteins and its applications of isolated proteins].
    Lai MD; Wang YH
    Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):76-8. PubMed ID: 17493378
    [No Abstract]   [Full Text] [Related]  

  • 8. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of proteomics in cancer gene profiling: two-dimensional difference in gel electrophoresis (2D-DIGE).
    Hariharan D; Weeks ME; Crnogorac-Jurcevic T
    Methods Mol Biol; 2010; 576():197-211. PubMed ID: 19882264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology.
    Rosty C; Christa L; Kuzdzal S; Baldwin WM; Zahurak ML; Carnot F; Chan DW; Canto M; Lillemoe KD; Cameron JL; Yeo CJ; Hruban RH; Goggins M
    Cancer Res; 2002 Mar; 62(6):1868-75. PubMed ID: 11912167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative proteomic analysis of differentially expressed proteins in human pancreatic cancer tissue.
    Chen JH; Ni RZ; Xiao MB; Guo JG; Zhou JW
    Hepatobiliary Pancreat Dis Int; 2009 Apr; 8(2):193-200. PubMed ID: 19357035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic analysis of lymph.
    Leak LV; Liotta LA; Krutzsch H; Jones M; Fusaro VA; Ross SJ; Zhao Y; Petricoin EF
    Proteomics; 2004 Mar; 4(3):753-65. PubMed ID: 14997497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New approaches to proteomic analysis of breast cancer.
    Wulfkuhle JD; McLean KC; Paweletz CP; Sgroi DC; Trock BJ; Steeg PS; Petricoin EF
    Proteomics; 2001 Oct; 1(10):1205-15. PubMed ID: 11721633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the regulatory proteins in human pancreatic cancers treated with Trichostatin A by 2D-PAGE maps and multivariate statistical analysis.
    Marengo E; Robotti E; Cecconi D; Hamdan M; Scarpa A; Righetti PG
    Anal Bioanal Chem; 2004 Aug; 379(7-8):992-1003. PubMed ID: 15257427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genes and proteins differentially expressed during in vitro malignant transformation of bovine pancreatic duct cells.
    Jesnowski R; Zubakov D; Faissner R; Ringel J; Hoheisel JD; Lösel R; Schnölzer M; Löhr M
    Neoplasia; 2007 Feb; 9(2):136-46. PubMed ID: 17356710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
    Chung JC; Oh MJ; Choi SH; Bae CD
    ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of pancreatic juice for the identification of biomarkers of pancreatic cancer.
    Park JY; Kim SA; Chung JW; Bang S; Park SW; Paik YK; Song SY
    J Cancer Res Clin Oncol; 2011 Aug; 137(8):1229-38. PubMed ID: 21691750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression profiling of human pancreatic adenocarcinoma and healthy pancreatic tissue.
    Lu Z; Hu L; Evers S; Chen J; Shen Y
    Proteomics; 2004 Dec; 4(12):3975-88. PubMed ID: 15526344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics and cancer diagnosis: the potential of mass spectrometry.
    Rodland KD
    Clin Biochem; 2004 Jul; 37(7):579-83. PubMed ID: 15234239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.